Molecular Modeling Studies of Anti-Alzheimer Agents by QSAR, Molecular Docking and Molecular Dynamics Simulations Techniques

Author:

Abdizadeh Rahman1ORCID,Hadizadeh Farzin2ORCID,Abdizadeh Tooba3ORCID

Affiliation:

1. Department of Medical Parasitology and Mycology, Faculty of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran

2. Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

3. Clinical Biochemistry Research Center, Basic Health Sciences Institute, Sharekord University of Medical Sciences, Shahrekord, Iran

Abstract

Background: Acetylcholinesterase (AChE), a serine hydrolase, is an important drug target in the treatment of Alzheimer's disease (AD). Thus, novel AChE inhibitors were designed and developed as potential drug candidates, for significant therapy of AD. Objective: In this work, molecular modeling studies, including CoMFA, CoMFA-RF, CoMSIA, HQSAR and molecular docking and molecular dynamics simulations were performed on a series of AChE inhibitors to get more potent anti-Alzheimer drugs. Methods: 2D/3D-QSAR models including CoMFA, CoMFA-RF, CoMSIA, and HQSAR methods were carried out on 40 pyrimidinylthiourea derivatives as data set by the Sybylx1.2 program. Molecular docking and molecular dynamics simulations were performed using the MOE software and the Sybyl program, respectively. Partial least squares (PLS) model as descriptors was used for QSAR model generation. Results: The CoMFA (q2, 0.629; r2ncv, 0.901; r2pred, 0.773), CoMFA-RF (q2, 0.775; r2ncv, 0.910; r2pred, 0.824), CoMSIA (q2, 0.754; r2ncv, 0.919; r2pred, 0.874) and HQSAR models (q2, 0.823; r2ncv, 0.976; r2pred, 0.854) for training and test set yielded significant statistical results. Conclusion: These QSAR models were excellent, robust and had good predictive capability. Contour maps obtained from the QSAR models were validated by molecular dynamics simulationassisted molecular docking study. The resulted QSAR models could be useful for the rational design of novel potent AChE inhibitors in Alzheimer's treatment.

Funder

Mashhad University of Medical Sciences

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery

Reference71 articles.

1. Bukhari S.N.A.; Jantan I.; Masand V.H.; Mahajan D.T.; Sher M.; Naeem-ul-Hassan M.; Amjad M.W.; Novel series of 1,2,4-trioxane derivatives as antimalarial agents. J Enzyme Inhib Med Chem 32(1), 1159-1173.2014

2. Bautista-Aguilera O.M.; Esteban G.; Bolea I.; Nikolic K.; Agbaba D.; Moraleda I.; Iriepa I.; Samadi A.; Soriano E.; Unzeta M.; Marco-Contelles J.; 2014

3. Vitorović-Todorović M.D.; Cvijetić I.N.; Juranić I.O.; Drakulić B.J.; 2012

4. Dighe S.N.; Deora G.S.; De la Mora E.; Nachon F.; Chan S.; Parat M.O.; Brazzolotto X.; Ross B.P.; Ross B.P.; 2016

5. Tam C.; Wong J.H.; Ng T.B.; Tsui S.K.W.; Zuo T.; Drugs for targeted therapies of Alzheimer’s disease 2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3